OrbiMed’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $16.1M | Hold |
|
|||||
|
2025
Q2 | $13.6M | Hold |
|
|||||
|
2025
Q1 | $10.4M | Hold |
|
|||||
|
2024
Q4 | $16.1M | Hold |
|
|||||
|
2024
Q3 | $59.2M | Sell |
|
|||||
|
2024
Q2 | $58M | Hold |
|
|||||
|
2024
Q1 | $84M | Hold |
|
|||||
|
2023
Q4 | $50.4M | Sell |
|
|||||
|
2023
Q3 | $48.3M | Hold |
|
|||||
|
2023
Q2 | $60.9M | Sell |
|
|||||
|
2023
Q1 | $71.7M | Hold |
|
|||||
|
2022
Q4 | $80.6M | Hold |
|
|||||
|
2022
Q3 | $63.2K | Hold |
|
|||||
|
2022
Q2 | $46.4K | Hold |
|
|||||
|
2022
Q1 | $91.3M | Hold |
|
|||||
|
2021
Q4 | $98.3M | Hold |
|
|||||
|
2021
Q3 | $66.4M | Hold |
|
|||||
|
2021
Q2 | $71.3M | Hold |
|
|||||
|
2021
Q1 | $103M | Hold |
|
|||||
|
2020
Q4 | $118M | Hold |
|
|||||
|
2020
Q3 | $64.8M | Hold |
|
|||||
|
2020
Q2 | $63M | Buy |
|